Trial Profile
Drug-drug interaction study of SMP-508 and sitagliptin.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2017
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 07 Jun 2016 New trial record